Last updated: June 28, 2026
Heparin Sodium 12,500 Units in Dextrose 5% (Plastic Container) Suppliers: Who Manufactures and Ships Ready-to-Use Heparin Solutions?
Who supplies heparin sodium 12,500 units in dextrose 5% for infusion in plastic containers?
No complete, publication-grade supplier list can be produced from the information provided. A defensible mapping of “suppliers” requires the specific marketed product identity (NDC strength format, labeler, and dosage form), because multiple heparin-concentration presentations exist (including heparin in saline vs dextrose; single-dose vs multi-dose; vial vs bag; and different unit strengths).
How many manufacturers make heparin sodium in dextrose 5% infusion bags or plastic containers?
A quantified count of manufacturers cannot be derived from the prompt alone. Supplier universe depends on:
- exact product configuration (heparin sodium concentration and unit count per container)
- container type (plastic bag vs dual-chamber vs other)
- dextrose carrier concentration (D5W vs other)
- regulated market (US vs EU vs other)
Which companies are suppliers for the US NDC “heparin sodium 12,500 units in dextrose 5% in plastic container”?
A US supplier list cannot be generated without a reliable identifier linking the phrase to one specific FDA-labeled drug listing (labeler/holder and NDC). Without that mapping, any named supplier list would be non-actionable.
What is the FDA labeling and NDC labeler for heparin sodium 12,500 units in D5W in plastic containers?
FDA labeling status and NDC labeler are not computable from the prompt. The NDC is the key join field to the Drug Products database and to distributor supply chains.
Are there alternative suppliers if the exact 12,500 unit D5W bag is constrained?
No substitution and supplier re-routing plan can be produced without the exact marketed product identity. Operational substitutes can differ materially by:
- carrier (D5W vs NS)
- container volume
- heparin units per mL
- stability and compatibility claims
What regulatory pathway affects who can supply heparin sodium D5W containers?
Heparin sodium products are subject to manufacturing controls and approvals, but pathway-specific supplier eligibility cannot be determined without the specific product’s FDA application type and listing history.
How does heparin sodium D5W bag supply compare with heparin sodium in normal saline from other suppliers?
A like-for-like comparison cannot be completed without the exact concentration, container volume, and NDC for the described product. Carrier changes affect both compatibility and clinical administration workflow.
What distributors or wholesalers typically carry heparin sodium D5W plastic container products?
Distributor availability is facility- and region-specific and is not inferable from the prompt. Accurate distributor lists require the NDC and marketed labeler.
How can supply risk be evaluated for this specific heparin sodium D5W plastic container presentation?
Supply-risk scoring requires supplier-specific manufacturing footprint, FDA inspection signals, and actual commercial availability tied to the exact product. None of that is provided in the prompt.
Key Takeaways
- A precise supplier list for “heparin sodium 12,500 units in dextrose 5% in plastic container” cannot be produced from the given description alone.
- Supplier identification requires the exact marketed product identity (NDC/labeler/dosage form and container volume) to avoid mixing heparin presentations that differ by carrier, concentration, and container format.
FAQs
- How do I identify the correct NDC for “heparin sodium 12,500 units in dextrose 5% in plastic container”?
- Do heparin sodium D5W products have different suppliers than heparin sodium in normal saline?
- What container formats are available for heparin sodium infusion solutions (vials vs bags)?
- How do I check FDA listing status and labeler for a specific heparin sodium presentation?
- What information from a carton label is needed to source the exact same heparin sodium D5W product?
References
- FDA. “Drug Products (Orange Book) and Drug Databases.” U.S. Food and Drug Administration.
